December 29, 2024 - 10:05

Rising sick leave rates may spell trouble for German companies grappling with an already struggling economy, but for private investigator Marcus Lentz, this trend has proven to be a lucrative opportunity. As more employees take time off for health reasons, Lentz has seen a significant increase in demand for his services.
Lentz specializes in uncovering potential fraud related to sick leave claims, a growing concern for employers facing financial strain. With many companies tightening their belts, the scrutiny on employee absences has intensified, prompting businesses to enlist Lentz's expertise. His investigations often involve discreet surveillance and thorough background checks to ensure that claims are legitimate.
The current economic climate has made companies more vigilant about protecting their resources, and Lentz's work highlights the delicate balance between employee rights and corporate accountability. As the trend of rising sick leave continues, Lentz's business is expected to thrive, demonstrating how challenging times can create unexpected opportunities.
July 31, 2026 - 04:21
Apple’s Sales Disappoint in China Unit, Services BusinessApple Inc. reported slower-than-expected sales growth in China and within its services segment during the last quarter, raising fresh concerns about the company`s performance in two of its most...
July 30, 2026 - 07:24
OpenAI’s ChatGPT reaches the coupon stage of building an ad businessOpenAI is moving into a familiar but telling stage of building an advertising business: the coupon offer. The company is preparing to hand out promotional ad credits to marketers, hoping to lure...
July 29, 2026 - 22:09
Chemical mix-up leads to hazmat response at Huntington Beach businessA hazardous materials response was launched Wednesday morning after a chemical reaction occurred at a business in Huntington Beach, prompting an evacuation of the site. Firefighters and hazmat...
July 29, 2026 - 00:41
FDA clears AI software for limiting false-positive ICM alertsThe U.S. Food and Drug Administration has cleared a new cloud-based artificial intelligence system designed to reduce false-positive alerts from implantable cardiac monitors. The software,...